RxDoctor Payments Data

Jeff Dyer, MD

Family Medicine · Kansas City, MONPI 1649215260

Payments from drug & device makers

$330in general payments, 2019–2025

Across 18 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$52
  • Novo Nordisk$37
  • Amgen$36
  • Boehringer Ingelheim$25
  • Abbott$23
  • AMAG Pharmaceuticals, Inc.$22
  • plus $135 from 8 others

What the payments were for

  • Food & beverage$30893%
  • Education$227%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$330 in reported general payments places this provider in the 45th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$37,113
Medicare patients
133
Services billed
537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$20,703
FarxigaDapagliflozin Propanediol12$19,769
MounjaroTirzepatide18$18,881
EliquisApixaban19$18,393
Repatha SureclickEvolocumab20$16,086
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$13,680
ShingrixVaricella-Zoster Ge/As01b/Pf46$10,059
JardianceEmpagliflozin16$9,569
MyrbetriqMirabegron11$7,800
Spiriva HandihalerTiotropium Bromide12$5,969
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate14$5,464
ArexvyRsvpref3 Antigen/As01e/Pf12$3,459
Ventolin HfaAlbuterol Sulfate25$1,998
Gabapentin59$1,716
Albuterol Sulfate HfaAlbuterol Sulfate54$1,573

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$37$20,70315 claims
AstraZenecaFarxiga$18$19,76912 claims
PfizerEliquis$14$18,39319 claims
Boehringer IngelheimJardiance$25$9,56916 claims
Astellas Pharma US IncMyrbetriq$19$7,80011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →